AIHealthcare Analytics

Overview

Neko Health is a preventive health company that uses AI to analyze full-body scans for early detection of health conditions. Founded in Sweden, the company has attracted major investment to expand its AI-powered scanning services into the United States.

Funding

Neko Health raised $700 million to fund its US market expansion (article 8). The raise is one of the largest single rounds in the digital health sector in 2026, reflecting strong investor appetite for AI-driven preventive health infrastructure.

Technology

Neko's platform combines medical-grade imaging hardware with AI analysis to produce comprehensive health assessments from a single scan session. The AI components analyze multiple organ systems and biomarkers simultaneously, generating risk profiles and flagging findings for physician review.

Market Context

The US expansion positions Neko against emerging preventive health competitors and established imaging networks. Regulatory pathway for the AI components under FDA's SaMD framework will be a key factor in the pace of US clinical deployment.